{"filings":[{"id":107431,"accession_number":"0001683168-26-001990","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2026-03-18T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Ruiming Zhou resigns from VitaNova Life Sciences board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Resignation effective March 12, 2026; no disagreements cited.","No replacement announced; board size not disclosed.","Company trades on OTC Pink Sheets under symbol VNOV."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107430,"accession_number":"0001683168-26-001300","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2026-02-25T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"VitaNova appoints CFO Steve Niu to its board of directors effective Feb 19, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board appointed Steve Niu, current CFO, as director effective Feb 19, 2026.","Niu will not receive any additional compensation for his director service.","Board determined Niu is not independent under Nasdaq governance standards.","Niu has been CFO since Jan 2024; previously President of Triangle Accounting (2001-2024).","No arrangements or family relationships requiring disclosure under Item 404(a)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107429,"accession_number":"0001683168-26-000571","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2026-01-27T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"VitaNova Life Sciences name change, 1-for-3 reverse split effective Jan 27","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name changed to VitaNova Life Sciences Corporation effective Jan 9; FINRA completed review as of Jan 27.","Reverse stock split at 1-for-3 ratio effected; trading on OTC Pink reflects split as of Jan 27.","Ticker to change to VNOV after 20 trading days under YJGJD; new CUSIP 98585W403.","No action required from stockholders for name change, split, or ticker symbol change."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":107432,"accession_number":"0001683168-26-000259","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2026-01-13T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"Yijia Group Corp. changes name to VitaNova Life Sciences Corp., effectuates 1-for-3 reverse stock split","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name changed to VitaNova Life Sciences Corp. effective Jan 9, 2026; FINRA processing ticker change.","Reverse stock split at 1-for-3 ratio approved; each three shares become one.","Authorized shares raised to 200M common, 10M preferred; 3M Series A Preferred shares designated.","Scrivener's error corrected via Certificate of Correction on Nov 21, 2025.","New CUSIP number 98585W403 obtained; evaluating new ticker symbol."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":123774,"accession_number":"0001683168-25-007445","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2025-10-07T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Yijia Group proposes name change to VitaNova Life Sciences, reverse split 1:2-1:3","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name changed to VitaNova Life Sciences Corporation approved by board and majority of shareholders.","Reverse stock split at ratio 1-for-2 to 1-for-3; ratio still being finalized.","Authorized capital increased to 75M common and 10M preferred shares ($0.0001 par).","Blank check preferred stock created with series, rights, and preferences set by board.","Company intends to file Certificate of Amendment with Nevada Secretary of State after finalizing split ratio."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":227844,"accession_number":"0001683168-24-004086","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2024-06-10T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Yijia Group Corp. terminates auditor Olayinka Oyebola & Co., appoints Simon & Edward, LLP","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Effective June 5, 2024, Board approved termination of OO & Co. as independent auditor and engagement of Simon & Edward, LLP.","Previous auditor's reports for FY 2022 and 2023 included going concern emphasis but no adverse opinion or disagreement.","No disagreements or reportable events occurred during fiscal years or subsequent interim period through June 4, 2024.","OO & Co. furnished letter agreeing with the disclosures, filed as Exhibit 16.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246638,"accession_number":"0001683168-24-000681","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2024-02-05T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Yijia Group Corp. raises $957K via private placement of ~19.1M shares at $0.05 each","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of $957,051; shares sold at $0.05 per share to 10 investors.","Two U.S. accredited investors (Reg D) and eight non-U.S. investors (Reg S) participated.","Shares are unregistered and subject to resale restrictions under the Securities Act.","Offering closed on January 30, 2024; conducted on a rolling basis with no minimum or maximum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":246637,"accession_number":"0001683168-24-000267","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2024-01-12T23:59:59+00:00","items":["5.02","8.01"],"status":"ready","headline":"Yijia Group CFO Qiuping Lu resigns; Dr. Steve Niu appointed as CFO effective Jan 8, 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Qiuping Lu resigned Jan 8, 2024; no disagreement with company on operations, policies or practices.","Board appointed Dr. Steve Niu as CFO effective same date; compensation $5,000/month paid in stock at $1/share (5,000 shares/month) after one year service.","Dr. Steve Niu, 61, has been President of Triangle Accounting since 2001 and professor at Shaw University; Ph.D. from Carleton University.","On Nov 9, 2023, co. founded Nutripeak Trading Corp, a wholly owned Nevada subsidiary, to manufacture and market healthcare products."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":281294,"accession_number":"0001683168-23-006408","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2023-09-14T23:59:59+00:00","items":["5.01","5.02"],"status":"ready","headline":"Yijia Group founder/CEO Xianchang Ma dies; heir gets 86.3% control; new CEO appointed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Founder and sole director Xianchang Ma passed away on August 3, 2023.","On Sept 12, 2023, heir Caihong Qu acquired 5,066,250 shares (86.3% of outstanding) at $0 consideration, gaining control.","Effective Sept 13, 2023, board comprises Qiuping Lu and Ruiming Zhou; Lu appointed CEO, President, and CFO.","Ms. Lu previously served as CEO and CFO of China Herb Group Holdings from 2014 to 2019.","Mr. Zhou has been a director at Shandong Tengjunxiang Biotechnology Co. since June 2017."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":300072,"accession_number":"0001683168-23-004181","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2023-06-15T23:59:59+00:00","items":["5.01","5.02","9.01"],"status":"ready","headline":"Xianchang Ma acquires 86.3% of Yijia Group; appointed CEO, President, CFO and Director","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Barry Sytner sold 5,066,250 shares (86.3% of outstanding) to Xianchang Ma for $470,562 on June 14, 2023.","Sytner resigned as CEO, President, CFO, and Director; Ma appointed to all those roles effective June 14, 2023.","Xianchang Ma, age 48, is CEO and director of Tengjun Biotechnology Corp; founded Jinan Tengiun Biological Technology in 2014.","Purchase price paid from Ma's personal funds; agreement included escrow and conditions such as filing of Form 10-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":392550,"accession_number":"0001683168-22-001045","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2022-02-16T23:59:59+00:00","items":["1.01","5.06","9.01"],"status":"ready","headline":"Yijia Group exits shell status by signing consulting agreements with Care365 and SBV","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Entered two consultant agreements on July 30, 2021: Care365 ($10k/month) and SBV ($5k/month).","Agreements are for 3-month terms, automatically renewing, providing financial consulting services.","Company states it is no longer a shell company under Rule 12b-2 due to more than nominal revenue from these deals.","Both agreements are arms-length and commenced August 2, 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":410905,"accession_number":"0001425203-21-000026","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2021-12-02T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Yijia Group Corp. dismisses Exelient PAC, engages Olayinka Oyebola & CO as new auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Exelient PAC resigned as independent auditor effective Nov 30, 2021; no disagreements reported.","New auditor Olayinka Oyebola & CO engaged Nov 29, 2021 for fiscal year ending April 30, 2022.","Former auditor's reports for FY2021 and FY2020 included a going-concern explanatory paragraph.","Board approved both the dismissal and appointment at a meeting on Nov 29, 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":429678,"accession_number":"0001425203-21-000002","cik":1699709,"company_name":"VitaNova Life Sciences Corp","ticker":"VNOV","form_type":"8-K","filed_at":"2021-08-05T23:59:59+00:00","items":["5.01","5.02","8.01"],"status":"ready","headline":"Barry Sytner acquires 86.3% of Yijia Group, becomes CEO; previous officers resign","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Barry Sytner purchased 5,066,250 common shares from officers/directors and majority shareholders on July 28, 2021.","The shares represent 86.3% of outstanding common stock, effective August 4, 2021, resulting in a change of control.","Shaoyin Wu, Kim Lee Poh, and Jian Yang resigned as officers and directors on July 28, 2021.","Barry Sytner, age 68, appointed CEO and Director; has over 40 years of business experience.","New management intends to pursue business consulting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":1.0,"calibrated_materiality_score":1.0,"market_cap_usd":null,"market_cap_bucket":null,"market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}